Multiple Vasostrict ANDAs Rival Eagle In Competitive Market

‘Market Is Crowded,’ Admits Peptide-Focused ANDA Sponsor Amphastar

Cut Dollars Slash Sales Forecast
The vasopressin opportunity is 'crowded' • Source: Maren Winter / Alamy Stock Photo

More from Products

More from Generics Bulletin